ORBIT Bleeding Risk Score

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
orbit total
—points (0-7)
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low0–2
  • Medium3–3
  • High4–7
Direct Clinical Answer

The ORBIT Bleeding Risk Score calculates stratifying cardiovascular risk, predicting thromboembolic events, or guiding therapeutic interventions. Key inputs include age ge 75. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

ORBIT bleeding risk score for atrial fibrillation (O'Brien 2015): Older age ≥75 (1), Reduced hemoglobin/anemia (2), Bleeding history (2), Insufficient kidney function eGFR <60 (1), Treatment with antiplatelet (1); total 0-7. 0-2 low, 3 medium, ≥4 high bleeding risk.

Clinical Indication

The ORBIT Bleeding Risk Score is indicated for bedside clinical practice to support ORBIT bleeding risk score for atrial fibrillation (O'Brien 2015): Older age ≥75 (1), Reduced hemoglobin/anemia (2), Bleeding history (2), Insufficient kidney function eGFR <60 (1), Treatment with antiplatelet (1); total 0-7. 0-2 low, 3 medium, ≥4 high bleeding risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.

Limitations & Contraindications

In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.

Clinical Pearls & Action Plan

Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.

Formula & Variables:

ORBIT = age≥75(1) + anemia(2) + bleeding history(2) + eGFR<60(1) + antiplatelet(1).

Input Parameters

NameTypeRequiredDescription
age_ge_75stringYesAge 75 or older
anemiastringYesReduced hemoglobin / anemia
bleeding_historystringYesHistory of bleeding
ckdstringYeseGFR <60 mL/min/1.73m²
antiplateletstringYesConcomitant antiplatelet treatment

Score Interpretation & Guidance

RangeStageDescription
0–2LowLow bleeding risk
3–3MediumMedium bleeding risk
4–7HighHigh bleeding risk

Evidence-Based References (EBM)

  • O'Brien EC, Simon DN, Thomas LE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36(46):3258-3264.

Related calculators